165469161	165469161	CD	B-NP	O
|	|	JJ	I-NP	O
R	R	NN	I-NP	O
|	|	NN	I-NP	O
87680508	87680508	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2052790	2052790	CD	B-NP	O
|	|	CC	I-NP	O
5/16/2006	5/16/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-ADJP	O
?	?	.	O	O

MYOCARDIAL	MYOCARDIAL	NNP	B-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/11/2006	4/11/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2006	10/20/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
PUSSER	PUSSER	NN	B-NP	O
,	,	,	O	O
ROLLAND	ROLLAND	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
arm	arm	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
arm	arm	NN	B-NP	O
paresthesias	paresthesia	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
47-year-old	47-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
includes	include	VBZ	B-VP	O
HIV	HIV	NN	B-NP	O
positive	positive	JJ	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
seizures	seizure	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
paresthesias	paresthesia	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
marches	march	VBZ	B-VP	O
proximally	proximally	RB	B-ADVP	O
up	up	RP	B-PRT	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	O	O
affecting	affect	VBG	B-VP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Along	Along	IN	B-PP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
occurring	occur	VBG	I-VP	O
approximately	approximately	RB	B-NP	O
five	five	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
notified	notify	VBN	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
frequency	frequency	NN	B-NP	O
since	since	IN	B-PP	O
having	have	VBG	B-VP	O
two	two	CD	B-NP	O
syncopal	syncopal	JJ	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
recalls	recall	VBZ	B-VP	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
episode	episode	NN	I-NP	O
occurring	occur	VBG	B-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bedroom	bedroom	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
antecedent	antecedent	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
consciousness	consciousness	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ground	ground	NN	I-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
help	help	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
came	come	VBD	B-VP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
witnessed	witness	VBN	I-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
postictal	postictal	JJ	I-NP	O
confusion	confusion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tongue	tongue	NN	I-NP	O
trauma	trauma	NN	I-NP	O
nor	nor	CC	O	O
was	be	VBD	B-VP	O
there	there	RB	B-ADVP	O
any	any	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
syncope	syncope	NN	B-NP	O
occurred	occur	VBD	B-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
arrival	arrival	NN	B-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
standing	stand	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
preceding	precede	VBG	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
post-event	post-event	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
called	call	VBD	B-VP	O
out	out	RB	B-ADVP	O
for	for	IN	B-PP	O
help	help	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
prior	prior	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
syncopal	syncopal	JJ	B-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
lifelong	lifelong	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
seizures	seizure	NNS	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
Keppra	Keppra	NNP	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
a	a	DT	I-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
prescription	prescription	NN	I-NP	O
has	have	VBZ	B-VP	O
ran	run	VBN	I-VP	O
out	out	RP	B-PRT	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
failed	fail	VBN	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
follow-up	follow-up	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
neurologist	neurologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Loock	Loock	NNP	I-NP	O
Both	Both	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
note	note	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
usually	usually	RB	B-ADVP	O
has	have	VBZ	B-VP	O
postictal	postictal	JJ	B-NP	O
confusion	confusion	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
events	event	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
fit	fit	VB	I-VP	O
that	that	DT	B-NP	O
description	description	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
like	like	IN	B-PP	O
her	her	PRP	B-NP	O
occasional	occasional	JJ	I-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
during	during	IN	B-PP	O
these	these	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
recently	recently	RB	B-ADVP	O
started	start	VBD	B-VP	O
Flexeril	Flexeril	NNP	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
admits	admit	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
three-pillow	three-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
new	new	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
four-block	four-block	JJ	I-NP	O
ambulation	ambulation	NN	I-NP	O
limited	limit	VBN	B-VP	O
by	by	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
notable	notable	JJ	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
dress	dress	NN	B-NP	O
size	size	NN	I-NP	O
from	from	IN	B-PP	O
18-14	18-14	CD	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
nine	nine	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
HIV	HIV	NN	B-NP	O
positive	positive	JJ	I-NP	O
,	,	,	I-NP	O
drug-seeking	drug-seeking	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
parotitis	parotitis	NN	B-NP	O
,	,	,	O	O
migraine	migraine	NN	B-NP	O
headaches	headache	NNS	I-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
panic	panic	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
seizures	seizure	NNS	B-NP	O
,	,	,	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
pancreatitis	pancreatitis	NN	B-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
Pap	Pap	NN	I-NP	O
smear	smear	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
cerebral	cerebral	JJ	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Flexeril	Flexeril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Truvada	Truvada	NNP	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Norvir	Norvir	NNP	B-NP	O
1400	1400	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Lomotil	Lomotil	NNP	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zofran	Zofran	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
325	325	CD	I-NP	O
mg/5	mg/5	NN	I-NP	O
mg	mg	NN	I-NP	O
tablets	tablet	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
trazodone	trazodone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Compazine	Compazine	NN	B-NP	O
,	,	,	O	O
Bactrim	Bactrim	NN	B-NP	O
,	,	,	O	O
didanosine	didanosine	NN	B-NP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	B-protein
,	,	,	O	O
cephalosporins	cephalosporin	NNS	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
stavudine	stavudine	NN	B-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
No.	No.	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
tetanus	tetanus	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
,	,	,	O	O
abacavir	abacavir	NN	B-NP	O
and	and	CC	I-NP	O
ritonavir	ritonavir	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
from	from	IN	B-PP	O
Reve	Reve	NNP	B-NP	O
Abilester	Abilester	NNP	I-NP	O
She	She	NNP	I-NP	O
is	be	VBZ	B-VP	O
living	live	VBG	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
and	and	CC	I-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
prior	prior	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
drinking	drink	VBG	B-VP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
early	early	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
father	father	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
74	74	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
76	76	CD	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.8	97.8	CD	I-NP	I-protein
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
172/80	172/80	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
middle-aged	middle-aged	JJ	I-NP	O
woman	woman	NN	I-NP	O
appearing	appear	VBG	B-VP	O
older	old	JJR	B-ADJP	O
than	than	IN	B-PP	O
stated	state	VBN	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
otherwise	otherwise	RB	B-VP	O
appears	appear	VBZ	I-VP	O
comfortable	comfortable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
disconjugate	disconjugate	JJ	I-NP	O
gaze	gaze	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
only	only	RB	B-NP	O
light	light	JJ	I-NP	O
vision	vision	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

Sclerae	Sclerae	NNS	B-NP	O
are	be	VBP	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
oral	oral	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
or	or	CC	I-NP	O
thrush	thrush	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nontender	nontender	JJ	B-ADJP	O
with	with	IN	B-PP	O
questionable	questionable	JJ	B-NP	O
splenic	splenic	JJ	I-NP	O
fullness	fullness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
4	4	CD	I-NP	O
x	x	NN	I-NP	O
4	4	CD	B-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
x	x	SYM	I-NP	O
2	2	CD	I-NP	O
scab	scab	NN	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
elbow	elbow	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
extending	extend	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
to	to	TO	B-PP	O
left	left	JJ	B-NP	O
elbow	elbow	NN	I-NP	O
was	be	VBD	B-VP	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
.	.	.	O	O

Aside	Aside	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
disconjugate	disconjugate	JJ	I-NP	O
gaze	gaze	NN	I-NP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Gait	Gait	NNP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
wide-based	wide-based	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
sufficient	sufficient	JJ	B-ADJP	O
without	without	IN	B-PP	O
cane	cane	NN	B-NP	O
.	.	.	O	O

Negative	Negative	JJ	B-NP	O
Romberg	Romberg	NNP	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
dysmetria	dysmetria	NN	I-NP	O
on	on	IN	B-PP	O
finger-to-nose	finger-to-nose	NN	B-NP	O
bilateral	bilateral	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
VALUES	VALUES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.9	3.9	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
179	179	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.2	9.2	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
35	35	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
57	57	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
51	51	CD	I-NP	I-protein
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
1.4	1.4	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
3.35	3.35	CD	B-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
12.6	12.6	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.7	36.7	CD	I-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
14.4	14.4	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
PTT	PTT	NN	B-NP	B-protein
29.5	29.5	CD	I-NP	I-protein
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
and	and	CC	I-NP	O
arm	arm	NN	I-NP	O
plain	plain	JJ	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fracture	fracture	NN	B-NP	O
or	or	CC	I-NP	O
dislocation	dislocation	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
47-year-old	47-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-NP	O
cerebral	cerebral	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	B-VP	O
taking	take	VBG	I-VP	O
Keppra	Keppra	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
syncopal	syncopal	JJ	I-NP	O
events	event	NNS	I-NP	O
without	without	IN	B-PP	O
prodrome	prodrome	NN	B-NP	O
and	and	CC	O	O
without	without	IN	B-PP	O
postictal	postictal	JJ	B-NP	O
state	state	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
thus	thus	RB	B-ADVP	O
unlikely	unlikely	JJ	B-ADJP	O
a	a	DT	B-NP	O
seizure	seizure	NN	I-NP	O
in	in	IN	B-PP	O
etiology	etiology	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
paresthesias	paresthesia	NNS	I-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
associated	associate	VBN	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
intermittently	intermittently	RB	I-VP	O
occurring	occur	VBG	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
recurrences	recurrence	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
syncopal	syncopal	JJ	B-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
issues	issue	NNS	I-NP	O
are	be	VBP	B-VP	O
related	relate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
syncopal	syncopal	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	I-NP	O
syndromes	syndrome	NNS	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
identified	identify	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
suspects	suspect	VBZ	B-VP	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spinous	spinous	JJ	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
potentially	potentially	RB	B-ADVP	O
arthritis	arthritis	NN	B-NP	O
,	,	,	O	O
disc	disc	NN	B-NP	O
herniation	herniation	NN	I-NP	O
or	or	CC	O	O
nerve	nerve	NN	B-NP	O
root	root	NN	I-NP	O
impingement	impingement	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
below	below	IN	B-PP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dictation	dictation	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
system	system	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

a.	a.	RB	B-ADVP	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
and	and	CC	O	O
taking	take	VBG	B-VP	O
antiretroviral	antiretroviral	JJ	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
about	about	IN	B-PP	O
associated	associate	VBN	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADVP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
exhibit	exhibit	VB	I-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
or	or	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Dyspnea	Dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
decondition	decondition	NN	B-NP	O
.	.	.	O	O

b.	b.	JJ	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
telemetry	telemetry	NN	I-NP	O
history	history	NN	I-NP	O
on	on	IN	B-PP	O
11/8/2006	11/8/2006	CD	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
nonsustained	nonsustained	JJ	I-NP	O
5-beat	5-beat	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
wide	wide	JJ	B-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
150	150	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
nonsustained	nonsustained	JJ	I-NP	O
4-beat	4-beat	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
narrow	narrow	JJ	B-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
to	to	TO	I-VP	O
review	review	VB	I-VP	O
the	the	DT	B-NP	O
telemetry	telemetry	NN	I-NP	O
strip	strip	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
referral	referral	JJ	B-ADJP	O
to	to	TO	B-PP	O
EP	EP	NNP	B-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
AICD	AICD	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Card	Card	NNP	I-NP	O
Service	Service	NNP	I-NP	O
wanted	want	VBD	B-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
ischemia-induced	ischemia-induced	JJ	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
adenosine	adenosine	NN	I-NP	B-DNA
MIBI	MIBI	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
telemetry	telemetry	NN	I-NP	O
strip	strip	NN	I-NP	O
was	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
EP	EP	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
diagnosed	diagnose	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
SVT	SVT	NN	I-NP	O
with	with	IN	B-PP	O
aberrancy	aberrancy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Card	Card	NNP	I-NP	O
Service	Service	NNP	I-NP	O
then	then	RB	B-ADVP	O
advised	advise	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
AICD	AICD	NNP	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
loop	loop	NN	I-NP	O
recorder	recorder	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
coordinated	coordinate	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PCP	PCP	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
metoprolol	metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
40	40	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
impairing	impair	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
change	change	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
indicated	indicate	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADVP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
and	and	CC	O	O
suggesting	suggest	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
indicated	indicate	VBN	I-VP	O
.	.	.	O	O

d.	d.	RB	B-NP	O
Miscellaneous	Miscellaneous	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
6/10/2006	6/10/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
diaphoretic	diaphoretic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
complained	complained	JJ	I-ADJP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
lying	lie	VBG	I-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
90/56	90/56	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
56	56	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
pallor	pallor	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
diaphoretic	diaphoretic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
described	describe	VBD	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
up	up	IN	B-ADVP	O
and	and	CC	I-ADVP	O
down	down	IN	I-ADVP	O
her	her	PRP$	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
in	in	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
event	event	NN	I-NP	O
spontaneously	spontaneously	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
in	in	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
15	15	CD	I-NP	O
minutes	minute	NNS	I-NP	O
without	without	IN	B-PP	O
medical	medical	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
convulsive	convulsive	JJ	B-NP	O
seizures	seizure	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noncompliant	noncompliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
12	12	CD	I-NP	O
months	month	NNS	I-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
neuro	neuro	NN	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sconiers	Sconiers	NNP	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
refills	refill	NNS	B-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
syncopal	syncopal	JJ	I-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
prodrome	prodrome	NN	B-NP	O
and	and	CC	O	O
without	without	IN	B-PP	O
postictal	postictal	JJ	B-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
were	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-NP	O
prior	prior	JJ	I-NP	O
seizures	seizure	NNS	I-NP	O
and	and	CC	O	O
unlikely	unlikely	JJ	B-NP	O
seizure	seizure	NN	I-NP	O
in	in	IN	B-PP	O
focus	focus	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EEG	EEG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
definite	definite	JJ	I-NP	O
focal	focal	JJ	I-NP	O
or	or	CC	I-NP	O
epileptiform	epileptiform	NN	I-NP	O
features	feature	NNS	I-NP	O
.	.	.	O	O

Keppra	Keppra	NNP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
after	after	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
after	after	IN	B-PP	O
another	another	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cerebral	cerebral	JJ	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
never	never	RB	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
Tonfay	Tonfay	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
and	and	CC	I-NP	O
MRA	MRA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
obtained	obtain	VBD	B-VP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemorrhage	hemorrhage	NN	B-NP	O
,	,	,	O	O
mass	mass	NN	B-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
hydrocephalus	hydrocephalus	NN	B-NP	O
,	,	,	O	O
infarction	infarction	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
high-flow	high-flow	JJ	I-NP	O
AVM	AVM	NN	I-NP	O
or	or	CC	I-NP	O
stenosis	stenosis	NN	I-NP	O
found	find	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
MRA	MRA	NN	B-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
neurologist	neurologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Klez	Klez	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
of	of	IN	B-PP	O
6.1	6.1	CD	B-NP	O
,	,	,	O	O
reflects	reflect	VBZ	B-VP	O
excellent	excellent	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	NNS	I-NP	O
becoming	become	VBG	B-VP	O
diaphoretic	diaphoretic	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
levels	level	NNS	I-NP	O
between	between	IN	B-PP	O
80	80	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
.	.	.	O	O

Given	Give	VBN	B-NP	O
recent	recent	JJ	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
without	without	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
dose	dose	NN	I-NP	O
adjustment	adjustment	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
glyburide	glyburide	NN	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
begin	begin	VB	I-VP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
all	all	DT	I-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Ryo	Ryo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
insulin	insulin	NN	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
CD4	CD4	NN	B-NP	B-protein
count	count	NN	I-NP	O
on	on	IN	B-PP	O
11/21/2006	11/21/2006	CD	B-NP	O
was	be	VBD	B-VP	O
217	217	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Truvada	Truvada	NNP	B-NP	O
and	and	CC	I-NP	O
Lexiva	Lexiva	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
on	on	IN	B-PP	O
7/26/2006	7/26/2006	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
symptoms	symptom	NNS	B-NP	O
resolved	resolve	VBN	B-VP	O
before	before	IN	B-PP	O
specimen	specimen	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
the	the	DT	B-NP	O
lab	lab	NN	I-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
lumbar	lumbar	NN	I-NP	O
spine	spine	NN	I-NP	O
herniations	herniation	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
methadone	methadone	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
155	155	CD	B-NP	O
mg	mg	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
additional	additional	JJ	I-NP	O
regular	regular	JJ	I-NP	O
narcotics	narcotic	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
normocytic	normocytic	JJ	I-NP	O
normochromic	normochromic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
index	index	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
anemia	anemia	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
HIV	HIV	NN	B-NP	O
immunosuppression	immunosuppression	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Miscellaneous	Miscellaneous	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Physical	Physical	NNP	I-NP	O
Therapy	Therapy	NNP	I-NP	O
Service	Service	NNP	I-NP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
coordinated	coordinate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Tlandgilb	Tlandgilb	NNP	I-NP	O
O	O	NNP	I-NP	O
Visiting	Visiting	NNP	I-NP	O
Nurses	Nurses	NNP	I-NP	O
Association	Association	NNP	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
liability	liability	NN	I-NP	O
and	and	CC	I-NP	O
predictability	predictability	NN	I-NP	O
of	of	IN	B-PP	O
events	event	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
implemented	implement	VBD	B-VP	O
a	a	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
autonomic	autonomic	JJ	B-NP	O
dysregulation	dysregulation	NN	I-NP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

Alternatively	Alternatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
speculates	speculate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
cervical	cervical	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
lumbar	lumbar	NN	B-NP	O
herniation	herniation	NN	I-NP	O
or	or	CC	O	O
nerve	nerve	NN	B-NP	O
root	root	NN	I-NP	O
impingement	impingement	NN	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
had	have	VBD	B-VP	O
occurred	occur	VBN	I-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
inpatient	inpatient	NN	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
receiving	receive	VBG	I-VP	O
her	her	PRP$	B-NP	O
Klonopin	Klonopin	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
only	only	RB	I-VP	O
received	receive	VBN	I-VP	O
three	three	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Klonopin	Klonopin	NN	B-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
six-day	six-day	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
what	what	WP	B-NP	O
role	role	NN	B-NP	O
anxiety	anxiety	NN	I-NP	O
is	be	VBZ	B-VP	O
playing	play	VBG	I-VP	O
into	into	IN	B-PP	O
these	these	DT	B-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
making	make	VBG	I-VP	O
arrangements	arrangement	NNS	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
an	an	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
specialist	specialist	NN	I-NP	O
at	at	IN	B-PP	O
Laly	Laly	NNP	B-NP	O
County	County	NNP	I-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

FINAL	FINAL	JJ	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Syncope	Syncope	NN	B-NP	O
,	,	,	O	O
not	not	RB	B-VP	O
otherwise	otherwise	RB	I-VP	O
specified	specify	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
arm	arm	NN	I-NP	O
pain/left	pain/left	NN	I-NP	O
chest	chest	NN	I-NP	O
pain/left	pain/left	NN	I-NP	O
arm	arm	NN	I-NP	O
paresthesias	paresthesia	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
not	not	RB	O	O
otherwise	otherwise	RB	B-NP	O
specified	specify	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Ecotrin	Ecotrin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Imodium	Imodium	NN	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
Truvada	Truvada	NNP	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lexiva	Lexiva	NNP	B-NP	O
1400	1400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
doses	dose	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
indefinitely	indefinitely	RB	I-ADVP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
155	155	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Zofran	Zofran	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

MEDICAL	MEDICAL	NNP	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
10/24/2006	10/24/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Les	Les	NNP	I-NP	O
Orosco	Orosco	NNP	I-NP	O
On	On	IN	B-PP	O
10/21/2006	10/21/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
psychiatrist	psychiatrist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Damien	Damien	NNP	I-NP	O
Scherzer	Scherzer	NNP	I-NP	O
On	On	IN	B-PP	O
4/8/2006	4/8/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Marion	Marion	NNP	I-NP	O
Callais	Callais	NNP	I-NP	O
On	On	IN	B-PP	O
7/6/2006	7/6/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
neurologist	neurologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Shane	Shane	NNP	I-NP	O
Bemberry	Bemberry	NNP	I-NP	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Na	Na	NNP	I-NP	O
Riventtortonlis	Riventtortonlis	NNP	I-NP	O
Jo	Jo	NNP	I-NP	O
VNA	VNA	NNP	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
do	do	VB	I-VP	O
a	a	DT	B-NP	O
medication	medication	NN	I-NP	O
reconciliation	reconciliation	NN	I-NP	O
and	and	CC	I-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

SPECIFIC	SPECIFIC	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
medications	medication	NNS	B-NP	O
as	as	IN	B-SBAR	O
listed	list	VBN	B-VP	O
,	,	,	O	O
clarify	clarify	VB	B-VP	O
discrepancies	discrepancy	NNS	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
means	mean	VBZ	B-VP	O
stop	stop	NN	B-NP	O
taking	take	VBG	B-VP	O
Flexeril	Flexeril	NNP	B-NP	O
,	,	,	O	O
____	____	NN	B-NP	O
glyburide	glyburide	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
low-dose	low-dose	JJ	B-NP	B-protein
aspirin	aspirin	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
faint	faint	VBP	B-VP	O
again	again	RB	B-ADVP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

If	If	IN	B-SBAR	O
your	your	PRP$	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
recur	recur	VBP	B-VP	O
and	and	CC	I-VP	O
persist	persist	VBP	I-VP	O
longer	longer	RBR	B-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
typical	typical	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and/or	and/or	CC	I-NP	O
return	return	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Make	Make	VB	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Smill	Smill	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Check	Check	VB	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
record	record	NN	B-NP	O
and	and	CC	O	O
bring	bring	VB	B-VP	O
your	your	PRP$	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

SPECIFIC	SPECIFIC	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
FOR	FOR	IN	B-PP	O
THE	THE	DT	B-NP	O
PCP	PCP	NN	I-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Please	Please	NN	B-NP	O
arrange	arrange	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
loop	loop	NN	I-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
studies	study	NNS	I-NP	O
assessing	assess	VBG	B-VP	O
for	for	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Adjust	Adjust	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-7289276	0-7289276	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MARTYN	MARTYN	NNP	B-NP	O
,	,	,	O	O
BRUNO	BRUNO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOTI	TOTI	NNP	B-NP	O
,	,	,	O	O
JEREMY	JEREMY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2660188	2660188	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/15/06	10/15/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/15/06	10/15/06	CD	B-NP	O

